X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.220
+0.170 (4.20%)
At close: Jun 18, 2026, 4:00 PM EDT
4.140
-0.080 (-1.90%)
After-hours: Jun 18, 2026, 5:04 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $398.03 million as of June 18, 2026. Its market cap has increased by 1,601.98% in one year.
Market Cap
398.03M
Enterprise Value
241.56M
1-Year Change
1,601.98%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $398.03M, an increase of 291.10%. That is a compound annual growth rate of 20.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 398.03M | 13.80% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 405.38M |
| Sagimet Biosciences | 403.24M |
| Eupraxia Pharmaceuticals | 393.20M |
| Editas Medicine | 391.33M |
| Lexeo Therapeutics | 391.04M |
| Larimar Therapeutics | 369.52M |
| Compass Therapeutics | 369.18M |
| Puma Biotechnology | 368.00M |